PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DX22FNUXF4556729287!entyvio 300 MG VIALS

The incumbent holds $737.3M across 100,503 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent SPE2DX15D9239. PoP ended Apr 18, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support

Awarding office

Apr 18, 2022

PoP end

$142K

Obligated

$142K

Potential

424210

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position — $90

Contract facts

Federal

Contract numberSPE2DX22FNUXF

Also listed asSPE2DX15D9239-SPE2DX22FNUXF

AgencyDla Troop Support

Awarding officeDla Troop Support

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

CAGE1UNB0

UEIPX72BSBQTKJ3

NAICS424210

No full NAICS 424210 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVSPE2DX15D9239

Place of performancePARK RIDGE IL

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startMar 28, 2022

PoP end (current)Apr 18, 2022

Obligated$142K

Current value$142K

Potential value$142K

4556729287!ENTYVIO 300 MG VIALS is a federal award for Dla Troop Support. Estimated value $142K ($142K obligated). Current period of performance ends Apr 18, 2022. Place of performance: PARK RIDGE IL.

Recompete timing

Public

● Past PoP end (1586 days ago)

Current PoP ended Apr 18, 2022 (1586 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Incumbent — $737.3M obligated across 100,503 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($737.3M) · all agencies

Department of Defense (DOD)$737.1M · 100%Department of Veterans Affairs (VA)$193K · 0%

Related awards

Same parent · incumbent

SPE2D026F0120

8511978882!OTHER MEDICAL

$248K

Apr 26, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract SPE2DX22FNUXF?

SPE2DX22FNUXF (4556729287!entyvio 300 MG VIALS) is a Dla Troop Support award with a potential value of $142K. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2DX22FNUXF?

Dla Troop Support awarded SPE2DX22FNUXF (potential $142K).

When does SPE2DX22FNUXF come up for recompete?

SCOUT tracks a period-of-performance end of Apr 18, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 1, 2026 · refreshed monthlyLatest procurement action Mar 28, 2022